Skip to main content
Adocia logo

Adocia — Investor Relations & Filings

Ticker · ADOC ISIN · FR0011184241 LEI · 969500ZL79KYH9PTYP78 PA Real estate activities
Open in API
Filings indexed 826 across all filing types
Latest filing 2021-06-02 Regulatory Filings
Country FR France
Listing PA ADOC

About Adocia

https://www.adocia.com

Adocia is a clinical-stage biotechnology company that specializes in developing innovative treatments for metabolic diseases, with a primary focus on diabetes and obesity. The company's core expertise is the development of novel formulations of approved peptides, proteins, and metabolic hormones, such as insulin, to improve their therapeutic efficacy. Adocia leverages proprietary technology platforms to create a pipeline of specialty products. Its research also extends to novel cell therapy approaches, including an immunoprotective scaffold for cell delivery. The company's business model involves advancing its product candidates to clinical proof-of-concept before licensing them to partners for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is a press release announcing that ADOCIA will present clinical results for its drug M1Pram at a specific medical conference (ATTD 2021). It details the session, date, time, and abstract information. This type of announcement, which communicates specific corporate news (clinical trial updates, conference participation) via a press release format, does not fit the definitions for formal regulatory filings (10-K, IR, ER, MRQ) or specific corporate actions (DIV, CAP, DIRS). It is a general corporate update regarding scientific progress. Since it is not a formal financial report, an earnings release, or a management discussion, the most appropriate classification is the general regulatory announcement fallback category, RNS, as it is a formal communication to the market about company activities, even if scientific in nature.
2021-06-02 English
Inside Information / Other news releases
Board/Management Information Classification · 1% confidence The document is titled with an announcement: "ADOCIA Reinforces Its Board of Directors with the Appointment of Three New Independent Members." It details the appointment of new directors and the resignation of an existing one, including biographical information about the appointees. This content directly relates to changes in the company's governing body, which aligns perfectly with the definition of Board/Management Information (MANG). It is not an earnings release (ER), a full annual report (10-K), or a proxy statement (PSI).
2021-06-01 English
Informations privilégiées / Autres communiqués
Board/Management Information Classification · 1% confidence The document is a press release dated June 1, 2021, announcing the appointment of three new independent members to Adocia's board of directors and the resignation of another member. This content directly relates to changes in the company's governing body (Board of Directors). This aligns perfectly with the definition for Board/Management Information (MANG). It is not an Annual Report (10-K), an Earnings Release (ER), or a proxy statement (DEF 14A/PSI).
2021-06-01 French
Inside Information / Other news releases
Earnings Release Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces specific corporate and clinical development news (patent filings, preclinical results, strategy updates) regarding obesity treatments. It is dated May 26th, 2021, and provides contact information. This format is characteristic of an Earnings Release (ER) or a general press release announcing significant, timely operational news, rather than a comprehensive annual report (10-K), a quarterly report (IR), or a formal regulatory filing like a DEF 14A or DVA. Since it announces key financial/operational highlights (patent filings, promising results) outside of a scheduled earnings call context, 'ER' (Earnings Release) is the most appropriate classification for a major operational announcement, although 'RNS' (Regulatory Filings) is a close secondary option if the announcement itself is considered a mandatory regulatory disclosure. Given the content focuses on clinical/patent milestones, ER is often used for such major operational updates preceding formal financial reports. FY 2021
2021-05-26 English
Informations privilégiées / Autres communiqués
Investor Presentation Classification · 1% confidence The document is a press release from the biopharmaceutical company Adocia announcing the filing of three patent families related to new hormone combinations for obesity treatment administered via pumps. It details preclinical results, management commentary, and future development plans. This type of announcement, focusing on R&D progress, intellectual property, and clinical pipeline updates, is characteristic of an Investor Presentation (IP) or a general corporate update. Since it is a detailed announcement of scientific and strategic progress aimed at investors, 'Investor Presentation' (IP) is the most fitting category, although it functions like a detailed press release. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a management discussion (MDA) of already released results. Given the depth of pipeline and strategy discussion, IP is preferred over a generic RNS.
2021-05-26 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document explicitly states its purpose: to release the 'total number of outstanding shares as well as its voting rights as of April 30, 2021,' citing French regulatory articles (L. 233-8 II of the French « Code de Commerce » and article 223-16 of the AMF charter). This type of mandatory disclosure regarding share capital structure and voting rights, often published as a press release, directly relates to changes in share ownership or capital structure reporting. While it is not a formal 'Director's Dealing' (DIRS) or a 'Share Issue' (SHA), it is a specific notification about the total share count and voting rights, which is a key component of major shareholding notifications or regulatory updates. Given the options, this specific disclosure about the total number of shares and voting rights aligns most closely with the scope of 'Major Shareholding Notification' (MRQ), as these reports often detail the denominator used for calculating ownership thresholds, or it could be classified as a general 'Regulatory Filing' (RNS). Since it is a specific, periodic disclosure mandated by the AMF regarding share counts, it fits better under MRQ than the general RNS fallback, although it is not strictly a notification of a change in a *specific* shareholder's stake, but rather the total base. However, looking closely at the definitions, 'Major Shareholding Notification (MRQ)' is for changes in *significant* ownership levels. This document reports the total base count, which is often published alongside or as a prerequisite for such notifications. Given the mandatory nature and the subject matter (share count/voting rights), it is a regulatory disclosure. If it were a change in a specific shareholder's stake, MRQ would be perfect. Since it's the total base count, it functions as a regulatory update. In many databases, these periodic share count updates are categorized under general regulatory announcements or sometimes under capital structure updates. Since it is a formal, mandated disclosure of share statistics, and does not fit perfectly into the other specific categories (like ER, 10-K, DIV), the most appropriate category is the general regulatory filing fallback, RNS, as it is a formal announcement required by the regulator (AMF). Alternatively, if the system prioritizes capital structure data, SHA might be considered, but SHA is usually for splits/issues. RNS is the safest fit for a mandatory, non-financial results regulatory announcement.
2021-05-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.